• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Novartis

    Tag: Novartis

    A big concern is the time it takes for generic drugs to be approved by the agency. (AP Photo/Gregory Bull)
    Business

    Novartis joins Pfizer in delaying drug price hikes

    Kimberly Leonard -
    July 18, 2018 11:38 am
    0
    Attorney Michael Cohen walks down the sidewalk in New York on Wednesday. Federal agents who raided the office of President Trump's personal attorney, were looking for information about payments to a former Playboy playmate and a porn actress who claim to have had affairs with Trump, two people familiar with the investigation said.
    Healthcare

    Top lawyer for Novartis retires following contract with Michael Cohen

    Melissa Quinn -
    May 16, 2018 4:42 pm
    0
    Senate Minority Leader Chuck Schumer, D-N.Y., left, joined by Sen. Patty Murray, D-Wash., and Sen. Ron Wyden, D-Ore., speaks during a new conference on Capitol Hill in Washington, Monday, June 26, 2017, about the Senate Republicans health care bill. Senate Republicans unveil a revised health care bill in hopes of securing support from wavering GOP lawmakers, including one who calls the drive to whip his party's bill through the Senate this week "a little offensive."
    Business

    Senate Dems press Novartis on payments to Trump fixer Michael Cohen

    Joe Williams -
    May 11, 2018 7:48 pm
    0
    On Wednesday, the Food and Drug Administration approved the first gene therapy in the U.S. called Kymriah, which customize a patient's own immune cells to fight a type of leukemia through a therapy called CAR-T. The drug's maker, Novartis, plans to sell the treatment for $475,000 for the one-time dose. (AP Photo/Andrew Harnik, File)
    Healthcare

    Revolutionary cancer treatment comes with hefty price tag

    Robert King -
    August 30, 2017 9:25 pm
    0
    Ohio and California aren't the only states to consider taking action on drug prices, but their effort goes the furthest. (Frank Polich/Bloomberg News)
    Healthcare

    Drug companies spend millions to fight price cap laws

    Robert King -
    December 29, 2015 5:01 am
    0
    Red Alert endorses Mitt Romney
    Red Alert Politics

    Red Alert endorses Mitt Romney

    Editorial Staff -
    November 1, 2012 6:04 pm
    0
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter